Pictet Asset Management Holding SA »

Immunovant shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $35M 1.2M 28.51
2024-03-31 $41M 1.3M 32.31

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Immunovant

Vanguard Group
BlackRock
BlackRock
Armistice Capital
T. Rowe Price Investment Management
Deep Track Capital
State Street Corporation
Perceptive Advisors
Viking Global Investors
Alpine Partners VI
Geode Capital Management
Woodline Partners
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA
Baker Bros. Advisors

View all funds holding Immunovant